Mallinckrodt Pharmaceuticals Blog
Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

Tuberous Sclerosis Alliance

Infantile Spasms Awareness Week December 1-7 Helps Spread the Word About Rare Seizure Disorder in Young Children

  • by Gena Holthaus
  • Posted on December 5, 2017
  • Advocacy
IS Image

By Molli Salzman, Mallinckrodt employee and mother of a child with infantile spasms When my son Charlie was a baby, I had a nagging feeling something wasn’t quite right. At the time, Charlie had two […]

Read More
  • Somerset County Land Dev Award (4)small

    Mallinckrodt Earns Somerset County Planning Board Land Development Honor

    February 21, 2018
  • Mallinckrodt Pharmaceuticals Named “2017 Shipper of the Year”

    December 12, 2017
  • Mallinckrodt’s Cathi Ponciroli Earns Missouri Lawyers Media’s inaugural In-House Counsel Award

    December 8, 2017
  • APICS story

    Supply Chain Transformation Garners Global Recognition for Mallinckrodt Specialty Generics

    December 5, 2017
  • IS Image

    Infantile Spasms Awareness Week December 1-7 Helps Spread the Word About Rare Seizure Disorder in Young Children

    December 5, 2017

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

Mallinckrodt Earns Somerset County Planning Board Land Development Honor

Somerset County Land Dev Award (4)small

Supply Chain Transformation Garners Global Recognition for Mallinckrodt Specialty Generics

APICS story

Infantile Spasms Awareness Week December 1-7 Helps Spread the Word About Rare Seizure Disorder in Young Children

IS Image

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
YouTube
LinkedIn
SHARE

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.